Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Experimental Brain Research
|
January 1, 1984
Enhanced GABA function in the angular complex (lateral periaqueductal grey matter and adjacent reticular formation) alters the postural component of striatal- or nigral-derived circling
C Reavill, S Muscatt, P N Leigh, et al.
Neuropharmacology
|
June 1, 1997
Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptors
L Thorn, T E Ashmeade, V J Storey, et al.
European Journal of Pharmacology
|
October 31, 1998
5-HT4 receptor antagonism does not affect motor and reward mechanisms in the rat
C Reavill, J P Hatcher, V A Lewis, et al.
Experimental Brain Research
|
January 1, 1987
Dopamine and somatostatin modulated adenylate cyclase activity in the rat caudate-putamen following unilateral cortical ablation
A Moser, C Reavill, A Liebetrau, et al.
Psychopharmacology
|
January 1, 1989
Nicotine and some related compounds: effects on schedule-controlled behaviour and discriminative properties in rats
S R Goldberg, M E Risner, I P Stolerman, et al.
Behavioural Brain Research
|
August 10, 1992
Photothrombotic lesions of the frontal cortex impair the performance of the delayed non-matching to position task by rats
D C Rogers, P W Wright, J C Roberts, et al.
Neuroscience
|
May 17, 2005
Mapping the effects of the selective dopamine D2/D3 receptor agonist quinelorane using pharmacological magnetic resonance imaging
M D Ireland, A S Lowe, C Reavill, et al.
Clinical Neuropharmacology
|
January 1, 1986
Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine
N M Rupniak, R S Briggs, M M Petersen, et al.
The Journal of Pharmacy and Pharmacology
|
June 1, 1983
Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the rat
S Fleminger, H van de Waterbeemd, N M Rupniak, et al.
Neuroscience
|
October 24, 2001
Up-regulation of secretoneurin immunoreactivity and secretogranin II mRNA in rat striatum following 6-hydroxydopamine lesioning and chronic L-DOPA treatment
A D Medhurst, B Y Zeng, K J Charles, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Experimental Brain Research
|
January 1, 1984
Enhanced GABA function in the angular complex (lateral periaqueductal grey matter and adjacent reticular formation) alters the postural component of striatal- or nigral-derived circling
C Reavill, S Muscatt, P N Leigh, et al.
Neuropharmacology
|
June 1, 1997
Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptors
L Thorn, T E Ashmeade, V J Storey, et al.
European Journal of Pharmacology
|
October 31, 1998
5-HT4 receptor antagonism does not affect motor and reward mechanisms in the rat
C Reavill, J P Hatcher, V A Lewis, et al.
Experimental Brain Research
|
January 1, 1987
Dopamine and somatostatin modulated adenylate cyclase activity in the rat caudate-putamen following unilateral cortical ablation
A Moser, C Reavill, A Liebetrau, et al.
Psychopharmacology
|
January 1, 1989
Nicotine and some related compounds: effects on schedule-controlled behaviour and discriminative properties in rats
S R Goldberg, M E Risner, I P Stolerman, et al.
Behavioural Brain Research
|
August 10, 1992
Photothrombotic lesions of the frontal cortex impair the performance of the delayed non-matching to position task by rats
D C Rogers, P W Wright, J C Roberts, et al.
Neuroscience
|
May 17, 2005
Mapping the effects of the selective dopamine D2/D3 receptor agonist quinelorane using pharmacological magnetic resonance imaging
M D Ireland, A S Lowe, C Reavill, et al.
Clinical Neuropharmacology
|
January 1, 1986
Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine
N M Rupniak, R S Briggs, M M Petersen, et al.
The Journal of Pharmacy and Pharmacology
|
June 1, 1983
Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the rat
S Fleminger, H van de Waterbeemd, N M Rupniak, et al.
Neuroscience
|
October 24, 2001
Up-regulation of secretoneurin immunoreactivity and secretogranin II mRNA in rat striatum following 6-hydroxydopamine lesioning and chronic L-DOPA treatment
A D Medhurst, B Y Zeng, K J Charles, et al.
Page
of 5